Search | IOVS | ARVO Journals

Showing 1 – 20 of 26

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

BEST1 gene augmentation therapy corrects light-modulated retinal micro-detachments

Karina E Guziewicz; Artur V Cideciyan; William A Beltran; Andras M Komaromy; Valerie Dufour; Malgorzata Swider; Simone Iwabe; Alexander Sumaroka; Brian T Kendrick; Gordon Ruthel; Vince A Chiodo; Elise Heon; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4522. doi:

ARVO Annual Meeting Abstract June 2017

Outcome measures for BEST1 gene augmentation therapy: restoration of RPE-photoreceptor interface homeostasis

Karina E Guziewicz; William A Beltran; Artur V Cideciyan; Valerie Liliane Dufour; Andras M Komaromy; Emily McTish; Alfred S Lewin; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2273. doi:

ARVO Annual Meeting Abstract June 2017

Long-term intraocular Pressure (IOP) control by means of a novel biodegradable intracameral (IC) latanoprost free acid (LFA) implant

Andras M Komaromy; Kristin Koehl; Christine D Harman; Gabriel Stewart; Noah Wolinski; Taylor N Norris; David Valade; Igor Chekhtman; John N Lambert; Andrew C Donohue; Russell Tait

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4591. doi:

ARVO Annual Meeting Abstract June 2017

Safety of a novel biodegradable intracameral (IC) latanoprost free acid (LFA) implant for long-term intraocular pressure (IOP) control

Kristin Koehl; Christine Harman; Gabriel Stewart; Noah Wolinski; Taylor N Norris; David Valade; Andrew C Donohue; Igor Chekhtman; John N Lambert; Russell Tait; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4592. doi:

ARVO Annual Meeting Abstract June 2017

Optimization of transgene expression in the trabecular meshwork (TM) by comparing capsid mutant AAV2 vectors

Christine Harman; Kristin Koehl; Annie Oh; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Shannon Elizabeth Boye; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4611. doi:

ARVO Annual Meeting Abstract June 2017

Quantitative and Qualitative Assessment of Retinal Degeneration in Canine Models of Inherited Retinal Diseases Using Spectral Domain Optical Coherence Tomography (SD-OCT)

Shin Ae Park; Jamie Rhodes; Simone Iwabe; Gui-Shuang Ying; J. Huang; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4869. doi:

ARVO Annual Meeting Abstract June 2015

In Vivo Gene Augmentation in the ADAMTS10 -Mutant Canine Trabecular Meshwork (TM) with Y444F-Capsid Mutant, Single-Stranded AAV2

Christine Harman; Annie Oh; Kristin L Koehl; Sanford L Boye; Vince Chiodo; Jiayan Huang; Gui-Shuang Ying; Shannon Elizabeth Boye; William W Hauswirth; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3648. doi:

ARVO Annual Meeting Abstract June 2015

Incomplete Achromatopsia in a Subgroup of Related CNGB3 -Mutant Dog

Kristin Koehl; Joshua Laske; Jennifer Rivera-Avales; Christine Harman; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4651. doi:

ARVO Annual Meeting Abstract June 2015

Assessment of rod, cone, and intrinsically photosensitive retinal ganglion cell (ipRGC) contribution to the canine chromatic pupillary response

Connie Yeh; Kristin L Koehl; Christine Harman; Simone Iwabe; Jose Guzman; Simon M Petersen-Jones; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5569. doi:

ARVO Annual Meeting Abstract June 2015

Long-term Cone ERG Functional Rescue in CNGB3 Mutant Achromatopsia Dogs by AAV-hCNGB3 Vectors Containing the PR1.7 Promoter and Packaged in AAV5, AAV9 or Mutant AAV2 Capsids

Andras M Komaromy; Guo-jie Ye; Christine Harman; Kristin L Koehl; Gustavo D Aguirre; Savitri Mandapati; Jeffrey D Chulay

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2066. doi:

ARVO Annual Meeting Abstract April 2014

Disease-based promoter selection for retinal gene therapy

Gustavo D Aguirre; Sem Genini; Andras M Komaromy; Karina E Guziewicz; William A Beltran

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):838. doi:

ARVO Annual Meeting Abstract April 2014

Targeting of Gene Expression to the wildtype and ADAMTS10-Mutant Canine Trabecular Meshwork by Non-Self-Complementary AAV2

Annie Oh; Christine Diane Harman; Kristin Koehl; Vince Chiodo; Sanford L Boye; Shannon Boye; William W Hauswirth; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5669. doi:

ARVO Annual Meeting Abstract April 2014

Photoreceptor-Targeted Gene Delivery Using Intravitreally Administered AAV Vectors in Dogs

Ryan F Boyd; Sanford L Boye; Shannon Boye; William W Hauswirth; Andras M Komaromy; Simon M Petersen-Jones; Joshua T Bartoe

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3331. doi:

ARVO Annual Meeting Abstract April 2014

Organotypic Culture System for the Adult Canine Retina

Hsiang-Rong Tsai; Ákos Lukáts; Arnold Szabo; Christine Diane Harman; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):360. doi:

ARVO Annual Meeting Abstract April 2014

Age effects on scleral mechanical properties of ADAMTS10-mutant and normal Beagle dogs

Joel Palko; Hugh J Morris; Xueliang Pan; Christine Diane Harman; Kristin Koehl; Kirk N Gelatt; Caryn Plummer; Andras M Komaromy; Jun Liu

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4264. doi:

Vision Sciences Society Annual Meeting Abstract August 2012

Staged gene therapy of canine retinal blindness does not produce cortical amblyopia for the later treated eye

Kris Walker; Andras M Komaromy; Gustavo D Aguirre; Geoffrey K Aguirre

Journal of Vision. 2012; 12(9):1360-1360. doi: 10.1167/12.9.1360

ARVO Annual Meeting Abstract March 2012

Scleral Viscoelastic Properties In A Canine POAG Model With ADAMTS10 Mutation

Joel Palko; Andras M. Komaromy; Simone Iwabe; Xueliang Pan; Jun Liu

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2801. doi:

ARVO Annual Meeting Abstract March 2012

Achromatopsia Caused by Genomic CNGB3 Deletion Identical by Descent in Multiple Canine Breeds

Connie Y. Yeh; Orly Goldstein; Debbie Holley; Heather J. Huson; Amy M. Knollinger; Sue E. Pearce-Kelling; Gregory M. Acland; Andras M. Komaromy

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4550. doi:

ARVO Annual Meeting Abstract March 2012

Cntf Induces A Transient Restoration Of Cone Function And Day Vision In Cngb3-achromatopsia

Andras M. Komaromy; Simone Iwabe; Jessica S. Rowlan; Alison D. Duncan; Shilpa Rao; Annie Oh; Rong Wen; Gustavo D. Aguirre

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5351. doi:

ARVO Annual Meeting Abstract April 2011

Measurement of Retinal Thickness in Canine Models of Outer Retinal Disease Using Spectral Domain Optical Coherence Tomography (SD-OCT)

James L. Rhodes; Simone Iwabe; Gui-shuang Ying; Jiayan Huang; Andras M. Komaromy

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1729. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

BEST1 gene augmentation therapy corrects light-modulated retinal micro-detachments

Outcome measures for BEST1 gene augmentation therapy: restoration of RPE-photoreceptor interface homeostasis

Long-term intraocular Pressure (IOP) control by means of a novel biodegradable intracameral (IC) latanoprost free acid (LFA) implant

Safety of a novel biodegradable intracameral (IC) latanoprost free acid (LFA) implant for long-term intraocular pressure (IOP) control

Optimization of transgene expression in the trabecular meshwork (TM) by comparing capsid mutant AAV2 vectors

Quantitative and Qualitative Assessment of Retinal Degeneration in Canine Models of Inherited Retinal Diseases Using Spectral Domain Optical Coherence Tomography (SD-OCT)

In Vivo Gene Augmentation in the ADAMTS10 -Mutant Canine Trabecular Meshwork (TM) with Y444F-Capsid Mutant, Single-Stranded AAV2

Incomplete Achromatopsia in a Subgroup of Related CNGB3 -Mutant Dog

Assessment of rod, cone, and intrinsically photosensitive retinal ganglion cell (ipRGC) contribution to the canine chromatic pupillary response

Long-term Cone ERG Functional Rescue in CNGB3 Mutant Achromatopsia Dogs by AAV-hCNGB3 Vectors Containing the PR1.7 Promoter and Packaged in AAV5, AAV9 or Mutant AAV2 Capsids

Disease-based promoter selection for retinal gene therapy

Targeting of Gene Expression to the wildtype and ADAMTS10-Mutant Canine Trabecular Meshwork by Non-Self-Complementary AAV2

Photoreceptor-Targeted Gene Delivery Using Intravitreally Administered AAV Vectors in Dogs

Organotypic Culture System for the Adult Canine Retina

Age effects on scleral mechanical properties of ADAMTS10-mutant and normal Beagle dogs

Staged gene therapy of canine retinal blindness does not produce cortical amblyopia for the later treated eye

Scleral Viscoelastic Properties In A Canine POAG Model With ADAMTS10 Mutation

Achromatopsia Caused by Genomic CNGB3 Deletion Identical by Descent in Multiple Canine Breeds

Cntf Induces A Transient Restoration Of Cone Function And Day Vision In Cngb3-achromatopsia

Measurement of Retinal Thickness in Canine Models of Outer Retinal Disease Using Spectral Domain Optical Coherence Tomography (SD-OCT)

To View More...

You must be signed into an individual account to use this feature.